D-0050-2021 Class II Terminated
FDA drug recall D-0050-2021 was initiated by RemedyRepack Inc. on Oct 11, 2020 and is designated Class II. Reason for recall: CGMP Deviations: detection of N-Nitrosodimethylamine (NDMA) impurity above the acceptable intake level (per manufacturer) The recall status is terminated (terminated Feb 24, 2021). Affected quantity: 79/30 count blister cards.
Recall details
- Product Type
- Drugs
- Report Date
- Nov 4, 2020
- Initiation Date
- Oct 11, 2020
- Termination Date
- Feb 24, 2021
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 79/30 count blister cards
Product description
Metformin Hydrochloride Extended Release 750 mg, 30 count blister cards, Rx only, Repackaged by: RemedyRepack Inc., Indiana, PA NDC 70518-2480-00
Reason for recall
CGMP Deviations: detection of N-Nitrosodimethylamine (NDMA) impurity above the acceptable intake level (per manufacturer)
Distribution pattern
Product was distributed to one customer in PA.
Code information
Lot Numbers: J0423350-121219 exp. date 12/31/2020 J0434828-020320 exp. date 02/28/2021 J0442511-031220 exp. date 03/31/2021 J0448429-040920 exp. date 04/30/2021 J0472499-081020, J0472532-081020 exp. date 08/31/2021
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0050-2021
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026